Korean biopharmaceutical firms join hands with foreign partners via technology transfer

Some Korean biopharmaceutical companies have teamed up with foreign partners in the biotechnology sector via technology tie-ups and joint research collaboration, according to the Korea Health Industry Development Industry (KHIDI).

Angiolab signed a contract with an Australian company to commercialize an anti-obesity drug. The company has pharmaceutical and nutraceutical compositions with sev...